The relationship between the metabolic rate and pharmacological actions of serotonin, bufotenine and psilocybin /

The relationship between the metabolic rate and pharmacological actions of serotonin, bufotenine and psilocybin /

42

Bibliographic Details
Main Author:	Gessner, P. K.
Format:
Subjects:	Serotonin Psilocybin

Similar Items

The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity
by: Rainer Kraehenmann, et al.
Published: (2016-01-01)

Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors
by: Robertas Strumila, et al.
Published: (2021-11-01)

The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers
by: Leor eRoseman, et al.
Published: (2014-05-01)

Persons With Spinal Cord Injury Report Peripherally Dominant Serotonin-Like Syndrome After Use of Serotonergic Psychedelics
by: Stephanie Karzon Abrams, et al.
Published: (2023-08-01)

Psychotherapy with Psilocybin for Depression: Systematic Review
by: Jonathan Joseph Dawood Hristova, et al.
Published: (2023-03-01)

Therapeutic use of psilocybin: Practical considerations for dosing and administration
by: Caroline A. MacCallum, et al.
Published: (2022-12-01)

Electrical spiking of psilocybin fungi
by: Antoni Gandia, et al.
Published: (2022-12-01)

Association of Psilocybin Use in Adolescents with Major Depressive Episode
by: K. Shah, et al.
Published: (2022-06-01)

Psilocybin—Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience
by: Vojtěch Viktorin, et al.
Published: (2022-06-01)

Psilocybin-Assisted Compassion Focused Therapy for Depression
by: Wendy Pots, et al.
Published: (2022-03-01)

Commentary: Effects of psilocybin on time perception and temporal control of behavior in humans
by: Katarina L Shebloski, et al.
Published: (2016-05-01)

Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review
by: Kristin Heuschkel, et al.
Published: (2020-03-01)

Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests
by: Grant Jones, et al.
Published: (2023-08-01)

Psilocybin's Emerging Role in Combating Depressive Disorder
by: Anna Jaremek, et al.
Published: (2023-08-01)

The Therapeutic Potential of Psilocybin
by: Henry Lowe, et al.
Published: (2021-05-01)

Effects of psilocybin-assisted therapy on treatment-resistant depression
by: A. Fraga, et al.
Published: (2021-04-01)

Rediscovering Psilocybin as an Antidepressive Treatment Strategy
by: Rene Zeiss, et al.
Published: (2021-09-01)

Psilocybin: From Serendipity to Credibility?
by: James J. Rucker, et al.
Published: (2021-04-01)

Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder
by: Jonathan Brett, et al.
Published: (2023-03-01)

Psilocybin and Mental Health–Don't Lose Control
by: Joseph M. Barnby, et al.
Published: (2018-07-01)

Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals
by: Anna Søndergaard, et al.
Published: (2022-10-01)

Esketamine and Psilocybin—The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review
by: Dominika Psiuk, et al.
Published: (2022-09-01)

The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice
by: Timur Zanikov, et al.
Published: (2023-03-01)

Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications
by: Orr Shahar, et al.
Published: (2022-11-01)

Production and extraction of psilocybin and psilocin from Psilocybe spp. mushrooms
by: Joana Margarida Costa Fernandes, et al.
Published: (2022-04-01)

Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?
by: Maurizio Coppola, et al.
Published: (2022-02-01)

Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?
by: N. Descalço, et al.
Published: (2021-04-01)

The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action
by: Daniela Dudysová, et al.
Published: (2020-12-01)

Christian Responses to Psilocybin-Assisted Therapy and Potential Religious and Spiritual Experiences
by: Brian Claude Macallan
Published: (2023-10-01)

Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees
by: Maggie Kamila Kiraga, et al.
Published: (2022-07-01)

Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy
by: Tara C. Malone, et al.
Published: (2018-04-01)

Evidence versus expectancy: the development of psilocybin therapy
by: James J. Rucker

Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DAD
by: Cesar Filho, et al.
Published: (2022-04-01)

Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience
by: Candace R. Lewis, et al.
Published: (2020-02-01)

Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge
by: Karolina Wąsik, et al.
Published: (2023-12-01)

Selling the Priceless Mushroom: A History of Psilocybin Mushroom Trade in the Sierra Mazateca (Oaxaca)
by: Marcos Garcia de Teresa
Published: (2022-12-01)

Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?
by: Antonio Munafò, et al.
Published: (2022-12-01)

Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis
by: Chia-Ling Yu, et al.
Published: (2022-02-01)

LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain
by: J Van Der Walt, et al.
Published: (2023-11-01)

Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects
by: Anders S. Olsen, et al.
Published: (2022-12-01)